Evaluation and Management of Dilated Main Pancreatic Duct

Risk Stratification Based on Duct Diameter

The American College of Radiology recommends that main pancreatic duct dilation is categorized as a "worrisome feature" when 5-9 mm in diameter and as "high-risk stigmata" when ≥10 mm in diameter, with a risk of malignant degeneration of approximately 57-92% for main duct IPMN compared to 25% for branch duct IPMN 1, 2, 3
Main duct IPMN carries a higher risk of malignant degeneration compared to branch duct IPMN, with an estimated risk of 57-92% 1, 3

The American College of Radiology recommends MRI with MRCP as the preferred initial imaging modality due to its high sensitivity for delineating pancreatic ductal anatomy, with the ability to detect additional worrisome features such as enhancing mural nodules, thick septations, or synchronous lesions 1, 3, 4
CT with pancreatic protocol (triphasic) is an alternative when MRI is contraindicated, but is less sensitive for ductal anatomy, as per the National Comprehensive Cancer Network 5

For main pancreatic duct dilation 5-9 mm, the American College of Radiology recommends proceeding to EUS-FNA for further evaluation, with MRI/MRCP performed prior to EUS-FNA to establish baseline characteristics and detect additional worrisome features 1, 2, 3
For main pancreatic duct dilation ≥10 mm, direct surgical referral is indicated due to high risk of malignancy, with no need for intermediate EUS-FNA step in this high-risk scenario 1, 2, 3

EUS-FNA is superior to MRI and CT for characterization of pancreatic ductal anatomy, with high spatial resolution imaging and ability to perform fluid analysis or tissue sampling 1, 3
The transgastric approach provides the greatest flexibility for pancreatic duct puncture, though transduodenal or transjejunal approaches may be used based on anatomy, as recommended by Gut 6
A 19-gauge needle with 0.035-inch or 0.025-inch guidewire is recommended for pancreatic duct access, as per Gut 6

In patients with surgically altered anatomy, EUS-guided pancreatic duct drainage may be necessary, with significantly higher technical and clinical success rates compared to enteroscopy-assisted approaches, as reported by Gut 6
The presence of multiple high-risk features has at least an additive effect on malignancy risk, as noted by Praxis Medical Insights 4

Delaying evaluation of pancreatic ducts with worrisome dilation (5-9 mm) can lead to delayed diagnosis of dysplasia or malignancy, with potential survival benefit for early diagnosis, as recommended by the American College of Radiology and Praxis Medical Insights 1, 3, 7